Objects
Tang, Monica, O'Connell, Rachel L., Amant, Frederic, Beale, Philip, McNally, Orla, Sjoquist, Katrin M., Grant, Peter, Davis, Alison, Sykes, Peter, Mileshkin, Linda, Moujaber, Tania, Kennedy, Catherine J., deFazio, Anna, Tan, King, Antill, Yoland, Goh, Jeffrey, Bonaventura, Tony, Scurry, James, Friedlander, Michael. Academic Press; 2019. PARAGON: a phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.
Bonaventura, Anthony, O'Connell, Rachel L., Martyn, Julie, DeFazio, Anna, Scurry, James, Friedlander, Michael L., Mapagu, Cristina, Beale, Philip J., McNally, Orla M., Mileshkin, Linda R., Grant, Peter T., Hadley, Alison M., Goh, Jeffery C. H., Sjoquist, Katrin M.. Lippincott Williams & Wilkins; 2017. Paragon (ANZGOG-0903): phase 2 study of Anastrozole in women with estrogen or progesterone receptor-positive platinum-resistant or -refractory recurrent ovarian cancer.
Mileshkin, Linda, Edmondson, Richard, O'Connell, Rachel L., Sjoquist, Katrin M., Andrews, John, Jyothirmayi, Rema, Beale, Philip, Bonaventura, Tony, Goh, Jeffrey, Hall, Marcia, Clamp, Andrew, Green, John, Lord, Rosemary, Amant, Frédéric, Alexander, Laura, Carty, Karen, Paul, James, Scurry, James, Millan, David, Nottley, Steven, Friedlander, Michael. Academic Press; 2019. Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: the PARAGON trial – ANZGOG 0903.
Byles, Julie E., Tavener, Meredith, Marley, John E., Goodger, Brendan G., O'Connell, Rachel L., Nair, Balakrishnan R., Higginbotham, Nick H., Jackson, Claire L., McKernon, Mary E., Francis, Lyn, Heller, Richard F., Newbury, Jonathan W.. Australasian Medical Publishing Company; 2004. Randomised controlled trial of health assessments for older Australian veterans and war widows.